Literature DB >> 28438864

Partial Deletions of Y-Chromosome in Infertile Men with Non-obstructive Azoospermia and Oligoasthenoteratozoospermia in a Turkish Population.

Cemallettin Cengiz Beyaz1, Sezgin Gunes2,3, Kadir Onem1, Tuba Kulac4, Ramazan Asci1,3.   

Abstract

Many genetic alterations have been identified to aid in understanding the genetic basis of male infertility, however, the cause of 30% of male infertility remains unknown. Some studies indicated that subdeletions of Y chromosome may be a reason for male infertility caused by testicular failure. In this regard, we aimed to investigate frequency of AZFc region subdeletions and their clinical effects in patients with idiopathic infertility. A total of 333 male infertile patients with non-obstructive azoospermia (NOA) or oligoasthenoteratozoospermia (OAT), and 87 normozoospermic controls were screened to detect gr/gr, b1/b3 and b2/b3 subdeletions. We recorded higher gr/gr deletion frequency in normozoospermic controls compared NAO and OAT groups (p=0.026). There were no significant differences in b2/b3 subdeletion rates among groups (p=0.437). In the OAT group, follicle-stimulating hormone levels of cases with b2/b3 deletion were statistically lower than cases without b2/b3 deletion (p=0.047). No statistical correlations were indicated among subdeletions, sperm count and assisted reproductive technology (ART) outcomes. These data demonstrate that gr/gr and b2/b3 subdeletions may not play a significant role in the etiopathogenesis of male infertility and ART outcomes in the studied population. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Non-obstructive azoospermia; Y chromosome deletion; b1/b3; b2/b3; gr/gr; male infertility; oligoasthenoteratozoospermia

Mesh:

Year:  2017        PMID: 28438864      PMCID: PMC5461446          DOI: 10.21873/invivo.11068

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  47 in total

1.  A family of human Y chromosomes has dispersed throughout northern Eurasia despite a 1.8-Mb deletion in the azoospermia factor c region.

Authors:  Sjoerd Repping; Saskia K M van Daalen; Cindy M Korver; Laura G Brown; Janet D Marszalek; Judith Gianotten; Robert D Oates; Sherman Silber; Fulco van der Veen; David C Page; Steve Rozen
Journal:  Genomics       Date:  2004-06       Impact factor: 5.736

2.  The b2/b3 subdeletion shows higher risk of spermatogenic failure and higher frequency of complete AZFc deletion than the gr/gr subdeletion in a Chinese population.

Authors:  Chuncheng Lu; Jie Zhang; Yingchun Li; Yankai Xia; Feng Zhang; Bin Wu; Wei Wu; Guixiang Ji; Aihua Gu; Shoulin Wang; Li Jin; Xinru Wang
Journal:  Hum Mol Genet       Date:  2008-12-16       Impact factor: 6.150

3.  The role of testicular biopsy in the modern management of male infertility.

Authors:  Richard A Schoor; Samir Elhanbly; Craig S Niederberger; Lawrence S Ross
Journal:  J Urol       Date:  2002-01       Impact factor: 7.450

Review 4.  Y chromosome b2/b3 deletions and male infertility: A comprehensive meta-analysis, trial sequential analysis and systematic review.

Authors:  Sandeep Kumar Bansal; Gopal Gupta; Singh Rajender
Journal:  Mutat Res Rev Mutat Res       Date:  2016-05-04       Impact factor: 5.657

5.  The Y chromosome gr/gr subdeletion is associated with male infertility.

Authors:  M Lynch; D S Cram; A Reilly; M K O'Bryan; H W G Baker; D M de Kretser; R I McLachlan
Journal:  Mol Hum Reprod       Date:  2005-07       Impact factor: 4.025

6.  Partial deletions in the AZFc region of the Y chromosome occur in men with impaired as well as normal spermatogenesis.

Authors:  K Hucklenbroich; J Gromoll; M Heinrich; C Hohoff; E Nieschlag; M Simoni
Journal:  Hum Reprod       Date:  2004-10-21       Impact factor: 6.918

7.  Features of constitutive gr/gr deletion in a Japanese population.

Authors:  Ho-Su Sin; Eitetsu Koh; Kazuyoshi Shigehara; Kazuhiro Sugimoto; Yuji Maeda; Atsumi Yoshida; Koichi Kyono; Mikio Namiki
Journal:  Hum Reprod       Date:  2010-07-27       Impact factor: 6.918

Review 8.  World Health Organization reference values for human semen characteristics.

Authors:  Trevor G Cooper; Elizabeth Noonan; Sigrid von Eckardstein; Jacques Auger; H W Gordon Baker; Hermann M Behre; Trine B Haugen; Thinus Kruger; Christina Wang; Michael T Mbizvo; Kirsten M Vogelsong
Journal:  Hum Reprod Update       Date:  2009-11-24       Impact factor: 15.610

9.  Diverse spermatogenic defects in humans caused by Y chromosome deletions encompassing a novel RNA-binding protein gene.

Authors:  R Reijo; T Y Lee; P Salo; R Alagappan; L G Brown; M Rosenberg; S Rozen; T Jaffe; D Straus; O Hovatta
Journal:  Nat Genet       Date:  1995-08       Impact factor: 38.330

10.  AZFc partial deletions in Chilean men with severe spermatogenic failure.

Authors:  María C Lardone; Daniela A Parodi; Mauricio Ebensperger; Paulina Peñaloza; Valeria Cornejo; Raúl Valdevenito; Ricardo Pommer; Andrea Castro
Journal:  Fertil Steril       Date:  2007-04-09       Impact factor: 7.329

View more
  4 in total

Review 1.  Paternal factors contributing to embryo quality.

Authors:  Stacy Colaco; Denny Sakkas
Journal:  J Assist Reprod Genet       Date:  2018-09-11       Impact factor: 3.412

Review 2.  Consequences of Y chromosome microdeletions beyond male infertility.

Authors:  Stacy Colaco; Deepak Modi
Journal:  J Assist Reprod Genet       Date:  2019-06-18       Impact factor: 3.412

Review 3.  Microtubular Dysfunction and Male Infertility.

Authors:  Sezgin Gunes; Pallav Sengupta; Ralf Henkel; Aabed Alguraigari; Mariana Marques Sinigaglia; Malik Kayal; Ahmad Joumah; Ashok Agarwal
Journal:  World J Mens Health       Date:  2018-10-22       Impact factor: 5.400

4.  Deletion of b1/b3 shows risk for expanse of Yq microdeletion in male offspring: Case report of novel Y chromosome variations.

Authors:  Xiangyin Liu; Hongguo Zhang; Yang Yu; Jia Fei; Yuting Jiang; Ruizhi Liu; Ruixue Wang; Guirong Zhang
Journal:  Medicine (Baltimore)       Date:  2020-09-11       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.